These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11450846)

  • 21. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.
    Chen C; Frierson HF; Haggerty PF; Theodorescu D; Gregory CW; Dong JT
    Genomics; 2001 Oct; 77(3):135-44. PubMed ID: 11597138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours.
    Cairns P; Polascik TJ; Eby Y; Tokino K; Califano J; Merlo A; Mao L; Herath J; Jenkins R; Westra W; Rutter JL; Buckler A; Gabrielson E; Tockman M; Cho KR; Hedrick L; Bova GS; Isaacs W; Koch W; Schwab D; Sidransky D
    Nat Genet; 1995 Oct; 11(2):210-2. PubMed ID: 7550353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization.
    Balázs M; Carroll P; Kerschmann R; Sauter G; Waldman FM
    Genes Chromosomes Cancer; 1997 Jun; 19(2):84-9. PubMed ID: 9171998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A common deletion at chromosomal region 17q21 in sporadic prostate tumors distal to BRCA1.
    Dai Q; Deubler DA; Maxwell TM; Zhu XL; Cui J; Rohr LR; Stephenson RA; Brothman AR
    Genomics; 2001 Feb; 71(3):324-9. PubMed ID: 11170749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses.
    Obermann EC; Junker K; Stoehr R; Dietmaier W; Zaak D; Schubert J; Hofstaedter F; Knuechel R; Hartmann A
    J Pathol; 2003 Jan; 199(1):50-7. PubMed ID: 12474226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homozygous deletions within the 11q13 cervical cancer tumor-suppressor locus in radiation-induced, neoplastically transformed human hybrid cells.
    Mendonca MS; Farrington DL; Mayhugh BM; Qin Y; Temples T; Comerford K; Chakrabarti R; Zainabadi K; Redpath JL; Stanbridge EJ; Srivatsan ES
    Genes Chromosomes Cancer; 2004 Apr; 39(4):277-87. PubMed ID: 14978789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancer.
    Srivatsan ES; Chakrabarti R; Zainabadi K; Pack SD; Benyamini P; Mendonca MS; Yang PK; Kang K; Motamedi D; Sawicki MP; Zhuang Z; Jesudasan RA; Bengtsson U; Sun C; Roe BA; Stanbridge EJ; Wilczynski SP; Redpath JL
    Oncogene; 2002 Aug; 21(36):5631-42. PubMed ID: 12165862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D.
    Paige AJ; Taylor KJ; Stewart A; Sgouros JG; Gabra H; Sellar GC; Smyth JF; Porteous DJ; Watson JE
    Cancer Res; 2000 Mar; 60(6):1690-7. PubMed ID: 10749141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low expression but infrequent genomic loss of the putative tumour suppressor DBCCR1 in astrocytoma.
    Beetz C; Brodoehl S; Patt S; Kalff R; Deufel T
    Oncol Rep; 2005 Feb; 13(2):335-40. PubMed ID: 15643521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
    Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR
    Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromosome-9 loss detected by fluorescence in situ hybridization in bladder cancer.
    Sauter G; Moch H; Carroll P; Kerschmann R; Mihatsch MJ; Waldman FM
    Int J Cancer; 1995 Apr; 64(2):99-103. PubMed ID: 7615360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequently deleted loci on chromosome 9 may harbor several tumor suppressor genes in human renal cell carcinoma.
    Grady B; Goharderakhshan R; Chang J; Ribeiro-Filho LA; Perinchery G; Franks J; Presti J; Carroll P; Dahiya R
    J Urol; 2001 Sep; 166(3):1088-92. PubMed ID: 11490304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localization of tumor suppressor gene associated with distant metastasis of urinary bladder cancer to a 1-Mb interval on 8p22.
    Ohgaki K; Iida A; Ogawa O; Kubota Y; Akimoto M; Emi M
    Genes Chromosomes Cancer; 1999 May; 25(1):1-5. PubMed ID: 10221333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peculiar structure and location of 9p21 homozygous deletion breakpoints in human cancer cells.
    Florl AR; Schulz WA
    Genes Chromosomes Cancer; 2003 Jun; 37(2):141-8. PubMed ID: 12696062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two regions of homozygous deletion clusters at chromosome band 9p21 in human lung cancer.
    Hamada K; Kohno T; Takahashi M; Yamazaki M; Yamazaki M; Tashiro H; Sugawara C; Ohwada S; Sekido Y; Minna JD; Yokota J
    Genes Chromosomes Cancer; 2000 Mar; 27(3):308-18. PubMed ID: 10679921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a homozygous deletion at 8p12-21 in a human prostate cancer xenograft.
    Van Alewijk DC; Van der Weiden MM; Eussen BJ; Van Den Andel-Thijssen LD; Ehren-van Eekelen CC; König JJ; van Steenbrugge GJ; Dinjens WN; Trapman J
    Genes Chromosomes Cancer; 1999 Feb; 24(2):119-26. PubMed ID: 9885978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Negative regulation of G(1)/S transition by the candidate bladder tumour suppressor gene DBCCR1.
    Nishiyama H; Gill JH; Pitt E; Kennedy W; Knowles MA
    Oncogene; 2001 May; 20(23):2956-64. PubMed ID: 11420708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer.
    Czerniak B; Chaturvedi V; Li L; Hodges S; Johnston D; Roy JY; Luthra R; Logothetis C; Von Eschenbach AC; Grossman HB; Benedict WF; Batsakis JG
    Oncogene; 1999 Feb; 18(5):1185-96. PubMed ID: 10022124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initiation-development modelling of allelic losses on chromosome 9 in multifocal bladder cancer.
    Louhelainen J; Wijkström H; Hemminki K
    Eur J Cancer; 2000 Jul; 36(11):1441-51. PubMed ID: 10899659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detailed marker chromosome analysis in cell line U-BLC1, established from transitional-cell carcinoma of the bladder.
    Bruch J; Wöhr G; Brüderlein S; Barbi G; Wolter H; Dixkens C; Mattfeldt T; Möller P; Paiss T; Hautmann R; Vogel W; Hameister H
    Int J Cancer; 1999 Mar; 80(6):903-10. PubMed ID: 10074925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.